Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

21 results about "In vivo" patented technology

Studies that are in vivo (Latin for "within the living"; often not italicized in English) are those in which the effects of various biological entities are tested on whole, living organisms or cells, usually animals, including humans, and plants, as opposed to a tissue extract or dead organism. This is not to be confused with experiments done in vitro ("within the glass"), i.e., in a laboratory environment using test tubes, Petri dishes, etc. Examples of investigations in vivo include: the pathogenesis of disease by comparing the effects of bacterial infection with the effects of purified bacterial toxins; the development of non-antibiotics, antiviral drugs, and new drugs generally; and new surgical procedures. Consequently, animal testing and clinical trials are major elements of in vivo research. In vivo testing is often employed over in vitro because it is better suited for observing the overall effects of an experiment on a living subject. In drug discovery, for example, verification of efficacy in vivo is crucial, because in vitro assays can sometimes yield misleading results with drug candidate molecules that are irrelevant in vivo (e.g., because such molecules cannot reach their site of in vivo action, for example as a result of rapid catabolism in the liver).

Device, system and method for magnetically maneuvering an in vivo device

ActiveUS20090048484A1GastroscopesOesophagoscopesIn vivoPhysical therapy
A method for controlling movement of an imaging device in vivo, the method comprising the steps of providing an imaging device having a longitudinal axis and a magnetic component, said device to be inserted into a patient's body; providing a rotating magnetic field outside the patient's body; and advancing the rotating magnetic filed along the patient's body in a desired direction.
Owner:GIVEN IMAGING LTD

Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling

InactiveUS7247618B2Sure easySuppression problemBiocideNervous disorderMammalSignalling pathways
Described herein are methods of inhibiting M-CSF activity, and, in particular, M-CSF/c-fms dependent cell signaling. In a first embodiment of the invention, one administers to a mammal viral vectors that deliver genes experessing antisense c-fms RNA; in a second embodiment, one induces in vivo production of a high-affinity soluble c-fms protein that competes for non-bound M-CSF; in a third embodiment, one administers a ribozyme-viral vector against c-fms mRNA; and in a fourth embodiment, one administers oligodeoxynucleotides that inhibit expression of c-fms gene product. The methods may be used to treat any disease in which M-CSF activity plays a role, and are particularly effective in treating and preventing atherosclerosis.
Embodiments of the present invention are directed primarily, but not exclusively, to a method for treating and preventing cardiovascular disease by inhibiting receptors to M-CSF. Other embodiments of the present invention include any and all biologic and/or pathobiologic phenomena mediated in whole or in part by M-CSF signaling through its receptor. Pathobiologic phenomena include, but are not limited to, disease entities such as osteoporosis, Alzheimer's disease, diabetes mellitus (Type 1 and/or Type 2), infectious diseases, cancer, and inherited disorders characterized by defects in one or more components in the M-CSF signaling pathway.
Owner:RAJAVASHISTH TRIPATHI

Fluorescent nano-particle with surface biological function, its production and use

InactiveCN1896738AWith organic functional groupsConvenient instructionsBiological testingFluorescence/phosphorescenceEmulsionIn vivo
This invention relates to a preparation method and its application of nuclear shell fluorescence nanometer particle whose surface living things is functional. The particle has nuclear shell structure, fluorescence material is hit in the inner core; the outer shell is composed of fluorescence transparency material; and there is embellishing organic function group in the outer covering. The nanometer particle is formed by the reversal tiny emulsion method, and doing chemical modification in the surface to make it to be biology functional nanometer particle. The nanometer particle has important application prospect in the fields such as cell biology, ultramicrochemistry, within the AMD chemistry, living things big molecule detecting and medical in-vivo diagnosing.
Owner:SHANGHAI NORMAL UNIVERSITY

Lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and preparation method of lung cancer and breast cancer compound preparation

InactiveCN105079005AGood inhibitory effectHigh anticancer activityEther/acetal active ingredientsRespiratory disorderPolyethylene glycolIn vivo
The invention discloses a lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and a preparation method of the lung cancer and breast cancer compound preparation. The lung cancer and breast cancer treatment compound preparation is made from erianin, taxol, bufalin and bruceine D according to a certain weight ratio. According to the preparation method, liposomes are prepared according to an ethyl alcohol injection method or dropping pills are prepared by taking polyethylene glycol as a base material to obtain the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine. The form of the compound preparation is compound liposomes and compound dripping pills. According to animal in-vivo anticancer pharmacological experiments, the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine has obvious inhibiting effect on growth of lung cancer and breast cancer and has higher anticancer activity than chemotherapeutic drug 5-fluorouracil.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Traditional Chinese medicine composition for treating hepatitis and liver cancer

InactiveCN101612179AReduce collagen contentPromote hyperplasiaOrganic active ingredientsDigestive systemHepatitisIn vivo
The invention discloses a traditional Chinese medicine composition for treating hepatitis and liver cancer, comprising the following raw material medicines according to parts by weight: 1 to 120 parts of rhein or rhubarb class substances capable of being metabolized into the rhein in vivo, 1 to 50 parts of quercetin or quercetinic acid glucoside class substances capable of metabolized into the quercetinic acid in vivo and 3 to 60 parts of vinegar radix bupleuri, wherein the rhein is a market-sold product artificially synthesized or naturally extracted, and the purity is more than or equal to 80%. The composition can be prepared into various traditional Chinese medicine preparation medicines which can suppress the multiplication of liver cancer cells and promote the death of the liver cancer cells; an animal experiment validates that compared with the original anticancer medicine, the medicine can greatly enhance the concentration of the medicine in the liver and prolong the detention time of the medicine.
Owner:NO 2 CLINICO MEDICINE COLLEGE GUANGZHOU UNIV OF TRADITIONAL CHINESE MEDICINE

Thymopentin methyl ester conjugate and preparation method thereof

InactiveCN106366177AEnhance immune balance regulationSolve the shortcoming that the half-life is only 30 secondsThymopoietinsPeptide preparation methodsN-ethyldiisopropylamineDistillation
The invention relates to a thymopentin methyl ester conjugate and a preparation method thereof. The preparation method specifically comprises the following steps: dissolving Z-FPSDM-Arg(Pbf)-Lys(BOC)-OH and 1-hydroxybenzotriazole (HOBt) / DCC / MMF in anhydrous trichloromethane, adding N,N-ethyldiisopropylamine and other specific solvents for reacting while stirring, thereby obtaining an active ester A; dripping the active ester into an alkaline solution of tripeptide derivatives, adding N,N-diisopropylamine and other specific solvents, thereby obtaining a coarse product of the thymopentin methyl ester conjugate; and finally, performing deprotection, reduced pressure distillation, washing and drying, thereby obtaining an accurately modified thymopentin methyl ester conjugate. The preparation method disclosed by the invention is fewer in byproducts and high in synthetic efficiency. The thymopentin methyl ester conjugate has the effects of maintaining the biological activity of TP-5, relieving or avoiding enzymolysis of TP-5 and further obviously prolonging the in-vivo metabolic half-life, and is extremely high in clinical application value.
Owner:SHANDONG BOCHUANG BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products